John P. Sharp - 20 May 2021 Form 4 Insider Report for PhaseBio Pharmaceuticals Inc

Role
Chief Financial Officer
Signature
/s/ John P. Sharp
Issuer symbol
N/A
Transactions as of
20 May 2021
Net transactions value
+$3,973
Form type
4
Filing time
24 May 2021, 18:11:39 UTC
Next filing
03 Sep 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PHASQ Common Stock Award $3,973 +1,419 +3.4% $2.80* 42,724 20 May 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were acquired under the PhaseBio Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).